The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.EBI
Glaxosmithkline
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.EBI
Glaxosmithkline
Discovery of Potent Inhibitors of Schistosoma mansoni NAD¿ Catabolizing Enzyme.EBI
University of Strasburg
Cyclic adenosine 5'-diphosphate ribose analogs without a"southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.EBI
University of Bath
Flavonoids as inhibitors of human CD38.EBI
University of Strasburg
Orally Bioavailable Enzymatic Inhibitor of CD38, EBI
Mitobridge (An Astellas)
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.EBI
Elixir Pharmaceuticals
Cyclic ADP Ribose Hydrolase (CD38) Inhibitors.EBI
Temple University
2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationships.EBI
Glaxosmithkline Research and Development